T1	Participants 481 500	autistic population
T2	Participants 566 582	infantile autism
T3	Participants 874 1072	Children between the ages 3 and 11 years (inclusive) with a DSM IV clinical diagnosis of autism and who were outpatients from a specialty clinic for children at Roozbeh Psychiatric Teaching Hospital
T4	Participants 1233 1306	cyproheptadine + haloperidol (Group A) or haloperidol + placebo (Group B)
T5	Participants 2919 2950	children with autistic disorder
